BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21994769)

  • 1. C7a, a biphosphinic cyclopalladated compound, efficiently controls the development of a patient-derived xenograft model of adult T cell leukemia/lymphoma.
    Guimaraes-Correa AB; Crawford LB; Figueiredo CR; Gimenes KP; Pinto LA; Grassi MFR; Feuer G; Travassos LR; Caires ACF; Rodrigues EG; Marriott SJ
    Viruses; 2011 Jul; 3(7):1041-1058. PubMed ID: 21994769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cyclopalladated complex interacts with mitochondrial membrane thiol-groups and induces the apoptotic intrinsic pathway in murine and cisplatin-resistant human tumor cells.
    Serrano FA; Matsuo AL; Monteforte PT; Bechara A; Smaili SS; Santana DP; Rodrigues T; Pereira FV; Silva LS; Machado J; Santos EL; Pesquero JB; Martins RM; Travassos LR; Caires AC; Rodrigues EG
    BMC Cancer; 2011 Jul; 11():296. PubMed ID: 21756336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effects of chloroquine/hydroxychloroquine mediated by inhibition of the NF-κB signaling pathway through abrogation of autophagic p47 degradation in adult T-cell leukemia/lymphoma cells.
    Fauzi YR; Nakahata S; Chilmi S; Ichikawa T; Nueangphuet P; Yamaguchi R; Nakamura T; Shimoda K; Morishita K
    PLoS One; 2021; 16(8):e0256320. PubMed ID: 34407152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importin β1 regulates cell growth and survival during adult T cell leukemia/lymphoma therapy.
    Ishikawa C; Senba M; Mori N
    Invest New Drugs; 2021 Apr; 39(2):317-329. PubMed ID: 32959166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-adult T‑cell leukemia/lymphoma activity of cerdulatinib, a dual SYK/JAK kinase inhibitor.
    Ishikawa C; Senba M; Mori N
    Int J Oncol; 2018 Oct; 53(4):1681-1690. PubMed ID: 30066853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Butein inhibits NF-κB, AP-1 and Akt activation in adult T-cell leukemia/lymphoma.
    Ishikawa C; Senba M; Mori N
    Int J Oncol; 2017 Aug; 51(2):633-643. PubMed ID: 28586006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia.
    Watanabe M; Ohsugi T; Shoda M; Ishida T; Aizawa S; Maruyama-Nagai M; Utsunomiya A; Koga S; Yamada Y; Kamihira S; Okayama A; Kikuchi H; Uozumi K; Yamaguchi K; Higashihara M; Umezawa K; Watanabe T; Horie R
    Blood; 2005 Oct; 106(7):2462-71. PubMed ID: 15956280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1- and type 2-infected cells by a caspase-3-dependent mechanism involving Bcl-2 cleavage.
    Mahieux R; Pise-Masison C; Gessain A; Brady JN; Olivier R; Perret E; Misteli T; Nicot C
    Blood; 2001 Dec; 98(13):3762-9. PubMed ID: 11739184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-adult T-cell leukemia/lymphoma effects of indole-3-carbinol.
    Machijima Y; Ishikawa C; Sawada S; Okudaira T; Uchihara JN; Tanaka Y; Taira N; Mori N
    Retrovirology; 2009 Jan; 6():7. PubMed ID: 19146708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymoquinone enhances the anticancer activity of doxorubicin against adult T-cell leukemia in vitro and in vivo through ROS-dependent mechanisms.
    Fatfat M; Fakhoury I; Habli Z; Mismar R; Gali-Muhtasib H
    Life Sci; 2019 Sep; 232():116628. PubMed ID: 31278946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro treatment of HTLV-1 and HTLV-2 infected cells with arsenic trioxide and interferon-alpha.
    Mahieux R; Hermine O
    Leuk Lymphoma; 2005 Mar; 46(3):347-55. PubMed ID: 15621824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engraftment and tumorigenesis of HTLV-1 transformed T cell lines in SCID/bg and NOD/SCID mice.
    Liu Y; Dole K; Stanley JR; Richard V; Rosol TJ; Ratner L; Lairmore M; Feuer G
    Leuk Res; 2002 Jun; 26(6):561-7. PubMed ID: 12007504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WRN-targeted therapy using inhibitors NSC 19630 and NSC 617145 induce apoptosis in HTLV-1-transformed adult T-cell leukemia cells.
    Moles R; Bai XT; Chaib-Mezrag H; Nicot C
    J Hematol Oncol; 2016 Nov; 9(1):121. PubMed ID: 27829440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fucoidan extracted from Cladosiphon okamuranus Tokida induces apoptosis of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.
    Haneji K; Matsuda T; Tomita M; Kawakami H; Ohshiro K; Uchihara JN; Masuda M; Takasu N; Tanaka Y; Ohta T; Mori N
    Nutr Cancer; 2005; 52(2):189-201. PubMed ID: 16201850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-X(L) is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples.
    Nicot C; Mahieux R; Takemoto S; Franchini G
    Blood; 2000 Jul; 96(1):275-81. PubMed ID: 10891462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Bcl-2 family proteins in adult T-cell leukemia/lymphoma: in vitro and in vivo effects of the novel Bcl-2 family inhibitor ABT-737.
    Ishitsuka K; Kunami N; Katsuya H; Nogami R; Ishikawa C; Yotsumoto F; Tanji H; Mori N; Takeshita M; Miyamoto S; Tamura K
    Cancer Lett; 2012 Apr; 317(2):218-25. PubMed ID: 22138435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EAPB0203, a member of the imidazoquinoxaline family, inhibits growth and induces caspase-dependent apoptosis in T-cell lymphomas and HTLV-I-associated adult T-cell leukemia/lymphoma.
    Moarbess G; El-Hajj H; Kfoury Y; El-Sabban ME; Lepelletier Y; Hermine O; Deleuze-Masquéfa C; Bonnet PA; Bazarbachi A
    Blood; 2008 Apr; 111(7):3770-7. PubMed ID: 18218850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis by using the new oral demethylating agent OR-2100.
    Watanabe T; Yamashita S; Ureshino H; Kamachi K; Kurahashi Y; Fukuda-Kurahashi Y; Yoshida N; Hattori N; Nakamura H; Sato A; Kawaguchi A; Sueoka-Aragane N; Kojima K; Okada S; Ushijima T; Kimura S; Sueoka E
    Blood; 2020 Aug; 136(7):871-884. PubMed ID: 32391874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult T-cell leukemia/lymphoma development in HTLV-1-infected humanized SCID mice.
    Banerjee P; Tripp A; Lairmore MD; Crawford L; Sieburg M; Ramos JC; Harrington W; Beilke MA; Feuer G
    Blood; 2010 Apr; 115(13):2640-8. PubMed ID: 20124219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of CDKN1A in adult T-cell leukemia/lymphoma despite overexpression of CDKN1A in human T-lymphotropic virus 1-infected cell lines.
    Watanabe M; Nakahata S; Hamasaki M; Saito Y; Kawano Y; Hidaka T; Yamashita K; Umeki K; Taki T; Taniwaki M; Okayama A; Morishita K
    J Virol; 2010 Jul; 84(14):6966-77. PubMed ID: 20444901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.